(R)-[18F]OF-NB1

N/A

Report date: 2025/11/21 17:41:04

NME

Base Information

Drug Name(R)-[18F]OF-NB1

Drug Alias Name(R)-[18F]OF-NB1

ClassificationSmall molecules > Heterocyclic drugsDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Radioactive diagnostic agent +[5]

Mechanisms of ActionPositron-emission tomography enhancers

TargetsGlutamate [NMDA] receptor subunit epsilon 2

Therapy Area/IndicationsNervous System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEmory University Westfälische Wilhelms-Universität Münster

China Registration ClassN/A

Develop Information

Active CompaniesWestfälische Wilhelms-Universität Münster Emory University

Inactive CompaniesN/A

Active IndicationsNervous System Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A